Home / Going-concern warnings / InspireMD, Inc.
Filed 2026-05-07 路 Form 10-Q 路 Accession 0001493152-26-021636 micro
Price before filing: $1.16 (2026-05-06 close, split/dividend-adjusted)
Market cap at flag: $85.2M (2026-05-07) 路 Latest: $33.4M (2026-10-16)
| Window | NSPR | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -29.6% | +0.7% | -30.4% | 2026-06-08 |
| 90 days | -37.9% | +5.2% | -43.1% | 2026-08-05 |
| 180 days | pending | pending | until 2026-11-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 2 insiders bought $20K (2 purchases)
30 days after: 1 insider sold $23K (1 sale); 4 insiders bought $346K (9 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Stuka Paul Director | Purchase | 1,517 | $1.12 | $2K | no | Form 4 |
| 2026-05-06 | Ward Scott R. Director | Purchase | 15,995 | $1.15 | $18K | no | Form 4 |
| 2026-05-07: red flag filed | |||||||
| 2026-05-07 | ROUBIN GARY S Director | Purchase | 90,000 | $1.18 | $106K | no | Form 4 |
| 2026-05-07 | Stuka Paul Director | Purchase | 6,378 | $1.15 | $7K | no | Form 4 |
| 2026-05-07 | Ward Scott R. Director | Purchase | 73,255 | $1.15 | $84K | no | Form 4 |
| 2026-05-08 | Stuka Paul Director | Purchase | 65,626 | $1.16 | $76K | no | Form 4/A |
| 2026-05-11 | Stuka Paul Director | Purchase | 10,000 | $1.19 | $12K | no | Form 4/A |
| 2026-05-12 | Slosman Marvin CEO and President, Director | Purchase | 21,000 | $1.20 | $25K | no | Form 4 |
| 2026-05-13 | Stuka Paul Director | Purchase | 10,000 | $1.16 | $12K | no | Form 4 |
| 2026-05-14 | Stuka Paul Director | Purchase | 5,000 | $1.15 | $6K | no | Form 4 |
| 2026-05-19 | Gleason Shane Thomas Chief Commercial Officer | Sale | 22,778 | $1.01 | $23K | no | Form 4 |
| 2026-05-27 | Stuka Paul Director | Purchase | 20,000 | $0.88 | $18K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-02-06 to 2026-06-06. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Therefore, there is substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.